公司资料
ACADIA Pharmaceuticals Inc. 股价、新闻与催化剂
- 股票代码:
- ACAD
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
19.89 USD (-1.29%)
收盘价
最后更新: 2026年10月1日
3.58B USD
市值
股价为何变动
截至 2026年10月1日，ACAD 下跌 1.29%，收于 $19.89。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Acadia Pharmaceuticals is a biopharmaceutical company focused on neuroscience and rare disease, with commercial products in areas such as psychosis and movement disorders. Its business combines marketed therapies with a pipeline aimed at CNS and specialty indications.
所在地与行业分类
Acadia is headquartered in the United States and listed on NASDAQ. It sits in specialty neuroscience biopharma.
商业模式特征
The company depends on product sales, launch execution, and pipeline expansion across CNS and rare disease. Investors watch revenue growth, label breadth, and development milestones.
生物医药行业定位
Acadia occupies a strong specialty-neuroscience niche within biotech. It has more commercial footing than a typical development-stage company, but still reacts to pipeline and launch developments.
未来催化剂
- Acadia’s catalysts are DAYBUE execution, near-term CNS franchise updates, and any label / commercial step that broadens the company’s growth base. The company’s value depends on turning its CNS assets into a more durable franchise.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。